Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of AGN-199201 and AGN-190584 in Presbyopia
NCT02197806Phase 2Completed
- Sponsor
- Allergan
- Start
- Jul 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pilocarpine, oxymetazoline in presbyopia, sponsored by Allergan. Started Jul 2014; status: completed.
02
Drugs
pilocarpineoxymetazoline
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT02197806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197806.